M.Sc. by Research in BioTherapeutics
Overview
Biotherapeutics are biologic-based medicines made from biological sources for the treatment of certain diseases. The global biopharma market is projected to reach a staggering $970.4 billion by 2030, with India’s own market soaring to $30 billion by 2025. Rising burden of cancer, genetic & metabolic diseases, and autoimmune diseases coupled with the approval of several disease-modifying therapies of these conditions are driving market growth.
The research-driven Master’s program will develop following competencies, which are aligned to current and futuristic demands of industry and academia:
The program’s focus on one-year exclusive research will equip graduates in end-to-end discovery and manufacture of biotherapeutic products:
Career Opportunities: After completing the program, the graduates can be employed by several multi-national biopharma companies such as:
High-end Labs Infrastructure for Experiential Learning
Major Labs
High-end Equipment
Advantage Hyderabad
The Master’s by research in Biotherapeutics is very timely seeing the exponential growth of life sciences-based industrial ecosystem in Hyderabad- the “Hub of Life Sciences”, in Asia housing the “Genome Valley”, “Medical Devices Park” and “Pharma City” having more than 800 life sciences companies with US$ 50 billion combined value; 20+ Lifesciences and MedTech Incubators – Highest for any city in the Country
Qualifying Degree
B.Sc. (Biological Sciences/non-Medical) / B.Sc. (4-year program) / MBBS /BDS /B.Pharm./ B.Tech./ B.V.Sc.
Marks / CGPA / CPI in Qualifying degree
Fee Structure
Rs. 1,00,000 per annum (Academic Fees)
For more information, please visit the Mahindra University website or contact the Admissions team at admissions@mahindrauniversity.edu.in
Semester-I
| Sr. No. | Course Code | Course Title | L | T | P | Credits |
|---|---|---|---|---|---|---|
| 1 | BT5120 | Introduction to Biotherapeutics and Techno- commercial landscape | 2 | 0 | 0 | 2 |
| 2 | BT5121 | Biosimilars | 2 | 0 | 0 | 2 |
| 3 | BT5122 | Molecular basis of disease and disease models | 3 | 0 | 0 | 3 |
| 4 | BT5123 | Biotherapeutic modalities | 3 | 0 | 2 | 4 |
| 5 | BT5124 | Bioprocess Technology: Upstream and Downstream | 3 | 0 | 2 | 4 |
| 6 | BT5125 | Biostatistics & Data Analysis | 2 | 0 | 2 | 3 |
| 7 | BT5126 | Biomanufacturing Biotherapeutics | 2 | 0 | 0 | 2 |
| Total | 20 |
Semester-II
| Sr. No. | Course Code | Course Title | L | T | P | Credits |
|---|---|---|---|---|---|---|
| 1 | BT5227 | Pharmacology and toxicology | 3 | 0 | 2 | 4 |
| 2 | BT5228 | Biopharmaceutical bioinformatics | 3 | 0 | 2 | 4 |
| 3 | BT5229 | Analytical and Functional characterization of biotherapeutics | 3 | 0 | 2 | 4 |
| 4 | BT5230 | Formulation development and delivery systems | 3 | 0 | 0 | 3 |
| 5 | BT5231 | Quality, Regulatory Affairs & Compliance | 2 | 0 | 0 | 2 |
| 6 | BT5232 | Pharmacovigilance | 1 | 0 | 0 | 1 |
| 7 | BT5233 | Biotech entrepreneurship and IPR considerations | 2 | 0 | 0 | 2 |
| Total | 20 |
Semester-III
| Sr. No. | Course Code | Course Title | L | T | P | Credits |
|---|---|---|---|---|---|---|
| 1 | BT5334 | Research Project or Internship | 0 | 0 | 40 | 20 |
| Total | 20 |
Semester-IV
| Sr. No. | Course Code | Course Title | L | T | P | Credits |
|---|---|---|---|---|---|---|
| 1 | BT5435 | Research Project or Internship | 0 | 0 | 40 | 20 |
| Total | 20 |
Total Credits: 20+20+20+20= 80
